1. Home
  2. RPRX vs EXPD Comparison

RPRX vs EXPD Comparison

Compare RPRX & EXPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Royalty Pharma plc

RPRX

Royalty Pharma plc

HOLD

Current Price

$39.70

Market Cap

16.2B

Sector

Health Care

ML Signal

HOLD

Logo Expeditors International of Washington Inc.

EXPD

Expeditors International of Washington Inc.

HOLD

Current Price

$151.33

Market Cap

16.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RPRX
EXPD
Founded
1996
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil Refining/Marketing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
16.2B
16.3B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
RPRX
EXPD
Price
$39.70
$151.33
Analyst Decision
Strong Buy
Hold
Analyst Count
3
10
Target Price
$46.00
$129.22
AVG Volume (30 Days)
4.3M
1.5M
Earning Date
11-05-2025
11-04-2025
Dividend Yield
2.21%
1.02%
EPS Growth
N/A
20.10
EPS
1.75
6.15
Revenue
$2,349,844,000.00
$11,167,760,000.00
Revenue This Year
$37.13
$3.06
Revenue Next Year
$1.48
N/A
P/E Ratio
$22.68
$24.64
Revenue Growth
3.70
12.54
52 Week Low
$24.05
$100.47
52 Week High
$41.24
$151.67

Technical Indicators

Market Signals
Indicator
RPRX
EXPD
Relative Strength Index (RSI) 57.50 75.95
Support Level $39.24 $144.93
Resistance Level $40.50 $147.87
Average True Range (ATR) 0.91 2.89
MACD -0.08 0.18
Stochastic Oscillator 76.02 98.14

Price Performance

Historical Comparison
RPRX
EXPD

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About EXPD Expeditors International of Washington Inc.

Based in the US, Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. Expeditors derives around 35% of consolidated gross revenue from airfreight, 30% from ocean freight, and 36% from customs brokerage and other services.

Share on Social Networks: